Bill Sponsor
House Bill 8073
116th Congress(2019-2020)
Improving COVID–19 Data Transparency Act
Introduced
Introduced
Introduced in House on Aug 21, 2020
Overview
Text
Sponsor
Introduced
Aug 21, 2020
Latest Action
Aug 21, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
8073
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Virginia
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
Florida
Democrat
New Jersey
Democrat
New Jersey
Democrat
Northern Mariana Islands
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Improving COVID-19 Data Transparency Act

This bill requires the Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services (HHS) to take certain actions with respect to reporting and modeling COVID-19 (i.e., coronavirus disease 2019) data. It also requires health information technology, as a condition of certification by HHS, to automatically generate and transmit reports of possible reportable conditions from electronic health records to public health agencies.

The CDC must standardize the reporting of COVID-19 data by governmental health departments, including information related to contact tracing and surveillance, hospital admissions and outcomes, outbreaks, and community compliance with preventive measures. The CDC must also post and periodically update this information on its website.

In addition, the CDC must provide sufficient information about federal COVID-19 models to allow them to be reproduced, and HHS must enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to study issues related to COVID-19 modeling, including the data sources used in the models.

The CDC must also deliver a weekly televised presentation that is open to the media on its Morbidity and Mortality Weekly Report, a publication that reports surveillance statistics and other public health information and recommendations.

Text (1)
August 21, 2020
Actions (2)
08/21/2020
Referred to the House Committee on Energy and Commerce.
08/21/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:45:25 PM